Maternal and perinatal outcome in eclampsia at a tertiary care center

Authors

  • Monika Dalal Department of Obstetrics and Gynecology, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
  • Sandhya Singh Department of Obstetrics and Gynecology, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
  • Meenakshi Chauhan Department of Obstetrics and Gynecology, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
  • Smiti Nanda Department of Obstetrics and Gynecology, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
  • Jagjit Dalal Department of Neonatology, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
  • Shikha Madan Department of Obstetrics and Gynecology, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20194350

Keywords:

Blood pressure, Eclampsia, Magnesium sulphate, Morbidity

Abstract

Background: Preeclampsia is the occurrence of hypertension in combination with proteinuria, developing after 20 weeks gestation in a previously normotensive non-proteinuric patient. The objective of this study was to study the prevalance of eclampsia at PGIMS, Rohtak. To study the clinical profile, maternal and perinatal outcome in eclamptic patients.

Methods: This is a retrospective study and case records of all eclampsia cases were analysed from the study period of January 2018 to December 2018.

Results: There were 113 cases of eclampsia out of 11,661 deliveries and prevalence of eclampsia was calculated to be 0.96%. Majority of the patients were not registered 95.57%. 58% of patients were Primigravidas. 56% of the patient in the age group of 21-25 years. Antepartum, intrapartum and postpartum eclampsia were 71%, 1.7% and 27% respectively. Caesarean section was the preferred mode of delivery and was performed in 57% cases. ICU admission was required in 25% and remaining cases were managed in general/eclampsia ward. All patients received MgSO4 by Zuspan regimen. 12% patient developed HELLP syndrome and pulmonary oedema developed in 6% patient. There were a total of 3.5% maternal deaths during the study period. Total percentage of perinatal deaths due to eclampsia was 23%.

Conclusions: Eclampsia continues to be one of the prime etiological factors for maternal and perinatal morbidity and mortality. This is due to lack of proper antenatal care, low socioeconomic condition and lack of education. Regular antenatal checkup, early recognition and proper management are vital to tackle this challenge. MgSo4 is the anticonvulsant of choice and Zuspan regimen of MgSO4 is effective in the management of eclampsia.

References

Wang H, Naghavi M, Allen C, Barber R, Bhutta Z, Carter A et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-544.

Berhe AK, Kassa GM, Fekadu GA, Muche AA. Prevalence of hypertensive disorders of pregnancy in Ethiopia: a systemic review and meta-analysis. BMC Pregnancy Childbirth. 2018;18:34.

Mahmoudi N. Eclampsia: a 13-year experience at a United States tertiary care center. J Womens Health Gender Based Med. 1999;8:495-500.

Shaikh SB, Jampala S, Devi S, Mallika. A study on maternal and perinatal out comes in cases of eclampsia admitting to government medical college and general hospital, Anantapuramu, Andhra Pradesh, India. Int J Reprod Contracept Obstet Gynecol. 2016;5(7):2146-50.

Sunita TH, Desai RM. Eclampsia in a Teaching Hospital: Incidence, clinical profile and response to Magnesium Sulphate by Zuspan's regimen. J Dent Med Sci. 2013;4(2):1-5.

Shakya B, Vaidya A. Overview of eclampsia at a tertiary care hospital. NJOG. 2013;8(2):46-9.

Das R, Biswas S. Eclampsia: The major cause of maternal mortality in eastern India. Ethiop J Health Sci J. 2015;25(2):111.

Chaturvedi S, Randive B, Mistry N. Availability of treatment for eclampsia in public health institutions in Maharashtra, India. J Health Popul Nutr. 2013;31(1);86-95.

Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ. 1995;50(7):499-500.

Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):323-33.

Berhe AK, Kassa GM, Fekadu GA, Muche AA. Prevalence of hypertensive disorders of pregnancy in Ethiopia: a systemic review and meta-analysis. BMC Preg Childbirth. 2018;18:34.

Acharya G, Schultz S. Eclampsia in Patan hospital: a two year retrospective study. J Nepal Med Asso. 1991;29:254-8.

Gautam (Bhattarai) SK, Paudel K, Silwal K. Management and Outcome of Pre-eclampsia/Eclampsia among patient admitted in maternity ward in tertiary hospital. J Inst Med. 2013;35:2.

Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.

Andersgaard AB, Herbst A, Johansen M. Eclampsia in Scandinavia: incidence, substandard care, and potentially preventable cases. Acta Obstet Gynecol Scand. 2006; 85(8):929-36.

Swain S, Ohha KN, Prakash A. Maternal and perinatal mortality due to eclampsia. Indian Pediatr. 1993;30(6):771-3.

Abbade JF, Roberto A, Costa A, Anice MVC, Vera TM, Marilza VC, et al. Scheme versus an alternative magnesium sulfate scheme: randomised clinical trial of magnesium serum concentrations. Hyper Preg. 2010;29(1):82-92.

Ghimire S . Eclampsia: feto-maternal outcomes in a tertiary care centre in Eastern Nepal. J Nepal Med Assoc. 2016;54(201):24-8.

Choudhary P. Eclampsia: A hospital based retrospective study. Kathmandu Univ Med J. 2003;1(4):237-41.

Jha R, Verma S, Jha SK. Eclampsia in Janakpur zonal hospital, Nepal: Favourable outcome with Magnesium sulphate. N J Obstet Gynaecol. 2007;2(1):16-9.

Khanum M, Ashraf F, Sahrin H. A clinical study of 100 cases of eclampsia in Rajshahi Medical College Hospital. TAJ. 2004;17(2):80-3.

Bushnell C, Chireau M. Preeclampsia and stroke: Risks during and after pregnancy. Stroke Res and Treat. 2011;2011:1-9.

Mattar F, Sibai BM. Eclampsia. VIII. Risk Factors for maternal morbidity. Am J Obstet Gynecol. 1990;163:1049-55.

Rana S, Kattel P. Eclampsia at a tertiary care hospital of Nepal: A five year study. Janaki Med College J Med Sci. 2018;6(2):14-21.

Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181-92.

Yakasai IA, Gaya SA. Maternal and fetal outcome in patients with eclampsia at Murtala Muhammad specialist Hospital Kano, Nigeria. Ann Af Med. 2011;10:4.

Kurude VN, Kokate PH, Saha D, Jha EK. Study of maternal and perinatal outcome in eclampsia. Paripex Ind J Res. 2017;6(4):63-5.

Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol. 1998;92(5):883-9.

Witlin AG. Prevention and treatment of eclamptic convulsions. Clin Obstet Gynecol. 1999;42(3):507-18.

Duhan L, Nanda S, Dahiya P, Chaudhary S. Sociodemographic profiling and study of maternal and perinatal outcome in patients suffering from eclampsia. Int J Reprod Contracept Obstet Gynecol. 2016;5(6):1870-3.

Pokharel N, Shrestha M, Regmi M. Maternal, fetal and new born outcomes in pre-eclampsia and eclampsia: a hospial based study. Health Renais. 2014;12(2):106-10.

Downloads

Published

2019-09-26

Issue

Section

Original Research Articles